<DOC>
	<DOCNO>NCT01431300</DOCNO>
	<brief_summary>The purpose study assess image quality Ablavar-enhanced MR angiography central vein chest , determine whether dose reduction perform maintain image quality . This prospective randomized study , healthy volunteer recruit undergo central vein magnetic resonance angiogram ( MRA ) . They receive either FDA-approved dose lower dose Ablavar . Quantitative qualitative analysis perform image .</brief_summary>
	<brief_title>Dose-varied Evaluation Ablavar-enhanced MR Angiography Central Veins Chest Healthy Participants</brief_title>
	<detailed_description />
	<criteria>healthy male female subject 1845 year age Pregnant lactating female know renal impairment allergy gadoliniumbased contrast metallic implant device claustrophobia .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>central vein</keyword>
	<keyword>thorax</keyword>
	<keyword>superior vena cava</keyword>
	<keyword>Central vein image</keyword>
</DOC>